SEC Form 4 · accession 0001493152-26-034772
Anixa Biosciences Inc · ANIX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Amit Kumar
Officer — Chief Executive Officer · Director
Period of report
Jul 27, 2026
Accepted (ET)
Jul 27, 2026 · 3:25 pm EDT
Rule 10b5-1 plan
box not checked
Issuer CIK
0000715446
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Jul 27, 2026 | P | 3,188 | $3.37 | A | 647,000 | D |
Table II — derivative securities
No Table II lines on this filing.